Intralipid Infusion & Fertility

What Is Intralipid?

Intralipid is a sterile, milky intravenous fat emulsion made from soybean oil, egg yolk phospholipids, glycerin, and water. It is FDA-approved as a source of calories and essential fatty acids for patients who need parenteral (IV) nutrition—not as a stand-alone “fertility drug.”

In fertility medicine, some specialists consider Intralipid as an optional adjunct for selected patients with recurrent implantation failure (RIF) or recurrent pregnancy loss (RPL), particularly when an immune-related mechanism is suspected. That use is off-label and should follow shared decision-making with a board-certified reproductive endocrinologist. Overview resources on fat emulsions appear in medical references such as ScienceDirect’s topic summary and the peer-reviewed literature on IV lipid emulsions.

Why Fertility Specialists Sometimes Discuss It

The immune context (simplified)

Successful pregnancy depends on a regulated maternal immune response at the implantation site. Natural killer (NK) cells and cytokines help govern that balance; when regulation is thought to be off, some clinics explore immunomodulatory options as part of a broader plan. That area is complex and still evolving; it is not the same for every patient.

How Intralipid may act (theory)

Laboratory and small clinical studies suggest Intralipid may:

• Modulate NK cell functional activity in some assays
• Influence cytokine patterns relevant to inflammation and implantation
• Interact with pathways such as PPARs (nuclear receptors involved in lipid and immune signaling)

What Does the Evidence Show?

Study results are mixed. Some meta-analyses and trials report better implantation, clinical pregnancy, or live birth rates in selected cohorts; others find no benefit or raise questions about study design, bias, and heterogeneity. A rigorous narrative: evidence is often rated low to moderate in quality, and large, definitive trials are still needed before anything can be called standard for all patients.

Professional societies urge caution. The American Society for Reproductive Medicine (ASRM) has published guidance on immunotherapy in IVF concluding there is insufficient evidence to recommend routine use of intravenous fat emulsions for infertile patients outside research contexts—see the ASRM immunotherapy in IVF guideline (2018) and related committee documents on asrm.org. ESHRE and others have similarly emphasized limited evidence for several immune adjuncts in RIF. Always rely on your own physician’s reading of current literature.

Who Might Be Offered Intralipid (if at all)?

When discussed, it is usually in the context of a full fertility work-up—not as a self-directed add-on. Scenarios that some specialists consider (not a checklist for every patient) include:

• Recurrent implantation failure after good-quality embryos
• Recurrent pregnancy loss with appropriate evaluation
• Selected cases with specialized immune testing—the value and interpretation of such testing remain debated, with no universal cutoff for “abnormal” NK activity

How Is It Given? (General Information)

Protocols vary by clinic and prescriber. Intralipid is infused intravenously, typically over roughly one to two hours with monitoring, using the concentration and volume ordered by your doctor. Timing relative to embryo transfer or the IVF cycle, and any repeat doses in early pregnancy, must follow your specialist’s written plan—not a generic online schedule.

Official prescribing information and labeling for lipid emulsions (ingredients, warnings, contraindications) should always be followed; see the drug label on DailyMed for FDA-current text.

Safety, Contraindications, and Side Effects

Intralipid has a long track record in nutrition, but any IV medication carries risk. Labeling and clinical sources describe possible reactions (e.g., allergy, effects on lipids) and contraindications that classically include serious egg/soy allergy and certain severe disorders of fat metabolism, per manufacturer directions. Pregnancy and lactation should be discussed with your OB/fertility team using current labeling. Report prior reactions to fat emulsions, lipid disorders, and significant liver or metabolic disease to your prescriber.

Some trials have reported conflicting results or raised safety questions; your physician should review primary literature with you, not this summary alone.

How CarePoint Infusion Can Help

At CarePoint Infusion Center, we do not determine whether you “need” Intralipid or order fertility treatment—that is the role of your reproductive endocrinologist. When your specialist prescribes Intralipid (or other IV medications) with a clear order, we can:

• Administer the infusion in a medically supervised outpatient setting
• Help coordinate scheduling around your IVF or transfer timeline as directed
• Monitor during the visit per protocol and your provider’s instructions

For general prior authorization help, you may also read our prior authorization for infusion therapy page.